These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 26458742)

  • 21. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
    Shibuya Y; Niu Z; Bryleva EY; Harris BT; Murphy SR; Kheirollah A; Bowen ZD; Chang CCY; Chang TY
    Neurobiol Aging; 2015 Jul; 36(7):2248-2259. PubMed ID: 25930235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.
    Guo JL; Narasimhan S; Changolkar L; He Z; Stieber A; Zhang B; Gathagan RJ; Iba M; McBride JD; Trojanowski JQ; Lee VM
    J Exp Med; 2016 Nov; 213(12):2635-2654. PubMed ID: 27810929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.
    Sepulveda-Diaz JE; Alavi Naini SM; Huynh MB; Ouidja MO; Yanicostas C; Chantepie S; Villares J; Lamari F; Jospin E; van Kuppevelt TH; Mensah-Nyagan AG; Raisman-Vozari R; Soussi-Yanicostas N; Papy-Garcia D
    Brain; 2015 May; 138(Pt 5):1339-54. PubMed ID: 25842390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
    Vega IE; Cui L; Propst JA; Hutton ML; Lee G; Yen SH
    Brain Res Mol Brain Res; 2005 Aug; 138(2):135-44. PubMed ID: 15913839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenic Role of RAGE in Tau Transmission and Memory Deficits.
    Kim Y; Park H; Kim Y; Kim SH; Lee JH; Yang H; Kim SJ; Li CM; Lee H; Na DH; Moon S; Shin Y; Kam TI; Lee HW; Kim S; Song JJ; Jung YK
    Biol Psychiatry; 2023 May; 93(9):829-841. PubMed ID: 36759256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of mouse models to study cell-to-cell transmission of pathological tau.
    Narasimhan S; Lee VMY
    Methods Cell Biol; 2017; 141():287-305. PubMed ID: 28882308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synaptic Contacts Enhance Cell-to-Cell Tau Pathology Propagation.
    Calafate S; Buist A; Miskiewicz K; Vijayan V; Daneels G; de Strooper B; de Wit J; Verstreken P; Moechars D
    Cell Rep; 2015 May; 11(8):1176-83. PubMed ID: 25981034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans.
    Weisová P; Cehlár O; Škrabana R; Žilková M; Filipčík P; Kováčech B; Prčina M; Wojčiaková Ľ; Fialová Ľ; Smolek T; Kontseková E; Žilka N; Novák M
    Acta Neuropathol Commun; 2019 Aug; 7(1):129. PubMed ID: 31391090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studying tau protein propagation and pathology in the mouse brain using adeno-associated viruses.
    Wegmann S; Bennett RE; Amaral AS; Hyman BT
    Methods Cell Biol; 2017; 141():307-322. PubMed ID: 28882310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease.
    Lau DH; Hogseth M; Phillips EC; O'Neill MJ; Pooler AM; Noble W; Hanger DP
    Acta Neuropathol Commun; 2016 May; 4(1):49. PubMed ID: 27193083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of TauC3 antibody and demonstration of its potential to block tau propagation.
    Nicholls SB; DeVos SL; Commins C; Nobuhara C; Bennett RE; Corjuc DL; Maury E; Eftekharzadeh B; Akingbade O; Fan Z; Roe AD; Takeda S; Wegmann S; Hyman BT
    PLoS One; 2017; 12(5):e0177914. PubMed ID: 28531180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer's disease.
    Bichmann M; Prat Oriol N; Ercan-Herbst E; Schöndorf DC; Gomez Ramos B; Schwärzler V; Neu M; Schlüter A; Wang X; Jin L; Hu C; Tian Y; Ried JS; Haberkant P; Gasparini L; Ehrnhoefer DE
    Mol Neurodegener; 2021 Jul; 16(1):46. PubMed ID: 34215303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tau interacts with SHP2 in neuronal systems and in Alzheimer's disease brains.
    Kim Y; Liu G; Leugers CJ; Mueller JD; Francis MB; Hefti MM; Schneider JA; Lee G
    J Cell Sci; 2019 Jul; 132(14):. PubMed ID: 31201283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies.
    Giacomini C; Koo CY; Yankova N; Tavares IA; Wray S; Noble W; Hanger DP; Morris JDH
    Acta Neuropathol Commun; 2018 May; 6(1):37. PubMed ID: 29730992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission.
    Mohamed NV; Herrou T; Plouffe V; Piperno N; Leclerc N
    Eur J Neurosci; 2013 Jun; 37(12):1939-48. PubMed ID: 23773063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurodegeneration and plasticity.
    Arendt T
    Int J Dev Neurosci; 2004 Nov; 22(7):507-14. PubMed ID: 15465280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuronal activity enhances tau propagation and tau pathology in vivo.
    Wu JW; Hussaini SA; Bastille IM; Rodriguez GA; Mrejeru A; Rilett K; Sanders DW; Cook C; Fu H; Boonen RA; Herman M; Nahmani E; Emrani S; Figueroa YH; Diamond MI; Clelland CL; Wray S; Duff KE
    Nat Neurosci; 2016 Aug; 19(8):1085-92. PubMed ID: 27322420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.